New Delhi, India

Sanjay Malhotra


Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • New Delhi, IN (2010)
  • Delhi, IN (2010)

Company Filing History:


Years Active: 2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sanjay Malhotra: Innovator in Anti-Inflammatory Research

Introduction

Sanjay Malhotra is a prominent inventor based in New Delhi, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory agents. With a total of two patents to his name, his work focuses on addressing various inflammatory and autoimmune diseases.

Latest Patents

Sanjay Malhotra's latest patents include innovations in monosaccharide derivatives and 5-lipoxygenase inhibitors. The first patent relates to monosaccharide derivatives that serve as anti-inflammatory agents. These compounds are designed to inhibit and prevent inflammation and associated pathologies, including conditions such as bronchial asthma, rheumatoid arthritis, and multiple sclerosis. The second patent focuses on 5-lipoxygenase inhibitors, which are useful in treating a range of inflammatory and autoimmune diseases, including chronic obstructive pulmonary disorder and atopic dermatitis. Both patents provide methods for preparing these compounds and their pharmaceutical applications.

Career Highlights

Sanjay Malhotra is currently associated with Ranbaxy Laboratories, Inc., where he continues to innovate in the pharmaceutical sector. His work has the potential to significantly impact the treatment of various inflammatory conditions, improving the quality of life for many patients.

Collaborations

Sanjay has collaborated with notable colleagues such as Ashwani Kumar Verma and Abhijit Ray, contributing to a dynamic research environment that fosters innovation.

Conclusion

Sanjay Malhotra's contributions to the field of anti-inflammatory research highlight his role as a key inventor in the pharmaceutical industry. His patents reflect a commitment to developing effective treatments for complex health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…